Metaculus Help: Spread the word
If you like Metaculus, tell your friends! Share this question via Facebook, Twitter, or Reddit.
Will stage-3 trials of MDMA as a medical treatment be completed, with results submitted to the FDA, by 2021?
3,4-methylenedioxy-methamphetamine is MDMA - commonly called ecstasy, molly, or X. MDMA has a storied history beginning from its synthesis in 1912, to its use in psychotherapy in the '60s and its advent into recreational use in popular culture. While being a Schedule I substance in the U.S., and in general a legally controlled substance around the world, it's argued the classification is based on outdated science and that the drug is over-criminalized.
MDMA chiefly acts as a releasing agent for serotonin, norepinephrine, and dopamine; here's how it works. It's taken recreationally to induce euphoria, sociability, relaxation, heightened sensation and sexuality, but also brings on short-term effects like dehydration and nausea, and potential long-term effects like paranoia and addiction. However, evidence for the true extent of harm from MDMA isn't rock-solid and it appears that side-effects can be mitigated through moderate usage and dosing. There is a body of evidence for the efficacy of MDMA-assisted psychiatric treatment, and many advocate that more research to evaluate MDMA's usefulness in this regard.
Non-profit MAPS, the Multidisciplinary Association for Psychedelic Studies, is the only organization with funding in MDMA clinical trials to assist in the treatment of PTSD and social anxiety in autistic adults. MAPS is pushing for FDA approval of a medically available MDMA, and they are poised to enter phase 3 clinical trials in 2017. This is the last stage of research which will address the safety and effectiveness of the drug, and they are looking at trials in 200-400 people over the next 4-5 years. Their findings, if successful, are expected for submission to the FDA for approval in 2021. However, the organization says it needs about $20 million to complete the trials. At that point, the results can go to the FDA to assess MDMA as a legal medical drug. Will this happen?
This question will resolve positively if by Jan 1st, 2021, the MDMA stage 3 trial is complete, with the results and an official application submitted to the FDA toward medical approval.
Metaculus help: Predicting
Predictions are the heart of Metaculus. Predicting is how you contribute to the wisdom of the crowd, and how you earn points and build up your personal Metaculus track record.
The basics of predicting are very simple: move the slider to best match the likelihood of the outcome, and click predict. You can predict as often as you want, and you're encouraged to change your mind when new information becomes available.
The displayed score is split into current points and total points. Current points show how much your prediction is worth now, whereas total points show the combined worth of all of your predictions over the lifetime of the question. The scoring details are available on the FAQ.
Note: this question resolved before its original close time. All of your predictions came after the resolution, so you did not gain (or lose) any points for it.
Note: this question resolved before its original close time. You earned points up until the question resolution, but not afterwards.
This question is not yet open for predictions.
Metaculus help: Community Stats
Use the community stats to get a better sense of the community consensus (or lack thereof) for this question. Sometimes people have wildly different ideas about the likely outcomes, and sometimes people are in close agreement. There are even times when the community seems very certain of uncertainty, like when everyone agrees that event is only 50% likely to happen.
When you make a prediction, check the community stats to see where you land. If your prediction is an outlier, might there be something you're overlooking that others have seen? Or do you have special insight that others are lacking? Either way, it might be a good idea to join the discussion in the comments.